In the same context, one of the potential targets of miR-122-5p was the cAMP response element binding protein 1 (CREB1), and mitogen-activated protein kinase 1 (MAPK1) which are crucial in the pathological sequence of DKD. This evidence concerns the gene MAP2K1 and diabetic kidney disease.